Susan Schneider
- Ophthalmology top 0.05%
- Radiology, Nuclear Medicine and Imaging top 0.2%
- Molecular Biology top 10%
- Epidemiology
- Oncology
- Co-authors
- David M. BrownPeter K. KaiserMark MichelsJeffrey S. HeierRobert Y. KimJudy P. SyG. SoubraneTsontcho Ianchulev
- Topics
- Retinal Diseases and Treatments (11 papers)Ocular Oncology and Treatments (10 papers)Glaucoma and retinal disorders (5 papers)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
Susan Schneider
30 papers receiving 4.4k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Ophthalmology 4.2k
- Radiology, Nuclear Medicine and Imaging 3.1k
- Molecular Biology 850
- Epidemiology 208
- Oncology 167
Countries citing papers authored by Susan Schneider
This map shows the geographic impact of Susan Schneider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Schneider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Schneider more than expected).
Fields of papers citing papers by Susan Schneider
This network shows the impact of papers produced by Susan Schneider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Schneider. The network helps show where Susan Schneider may publish in the future.
Co-authorship network of co-authors of Susan Schneider
This figure shows the co-authorship network connecting the top 25 collaborators of Susan Schneider. A scholar is included among the top collaborators of Susan Schneider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Schneider. Susan Schneider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Patients With Neovascular Age-Related Macular Degeneration: Studies in Japan and the United States | 1 |
| 2 | 95 | |
| 3 | 55 | |
| 4 | 2 | |
| 5 | 14 | |
| 6 | Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1breakdown → | 693 |
| 7 | 306 | |
| 8 | 9 | |
| 9 | 3 | |
| 10 | 15 | |
| 11 | 14 | |
| 12 | 13 | |
| 13 | 40 | |
| 14 | 13 | |
| 15 | 36 | |
| 16 | 7 | |
| 17 | 1 | |
| 18 | 89 | |
| 19 | 43 | |
| 20 | 13 |
About Susan Schneider
Susan Schneider is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 31 papers that have together received 4.6k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (11 papers), Ocular Oncology and Treatments (10 papers) and Glaucoma and retinal disorders (5 papers). The work is most often cited by research in Ophthalmology (4.2k citations), Radiology, Nuclear Medicine and Imaging (3.1k citations) and Molecular Biology (850 citations). Susan Schneider has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include David M. Brown, Peter K. Kaiser, Mark Michels, Jeffrey S. Heier, Robert Y. Kim, Judy P. Sy, G. Soubrane, Tsontcho Ianchulev, Carl D. Regillo and Prema Abraham. Their work appears in journals such as New England Journal of Medicine, Ophthalmology and European Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.